Cargando…
Fibronectin-targeted dual-acting micelles for combination therapy of metastatic breast cancer
Stage IV breast cancer, which has a high risk of invasion, often develops into metastases in distant organs, especially in the lung, and this could threaten the lives of women. Thus, the development of more advanced therapeutics that can efficiently target metastatic foci is crucial. In this study,...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005157/ https://www.ncbi.nlm.nih.gov/pubmed/32296050 http://dx.doi.org/10.1038/s41392-019-0104-3 |